Infigratinib in Recurrent High-Grade Glioma Patients
Clinical trial NCT04424966 · TERMINATED
Trial details
- NCT number
- NCT04424966
- Sponsor
- Nader Sanai
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-21
- Primary completion
- 2023-01-31
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.